<DOC>
	<DOCNO>NCT01435174</DOCNO>
	<brief_summary>End-stage renal disease ( ESRD ) patient often develop cardiovascular complication , cardiovascular disease lead cause death population . Ranolazine 's ability treat angina without reduce heart rate blood pressure make important option ESRD patient . The hemodialysis clearance ranolazine unknown . A single-dose pharmacokinetic study need characterize ranolazine metabolite ESRD patient hemodialysis . Results propose study provide initial dosing estimate follow-up , multiple-dose pharmacokinetic study population .</brief_summary>
	<brief_title>Pharmacokinetics Single-Dose Oral Ranolazine Hemodialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Dialysis Solutions</mesh_term>
	<mesh_term>Ranolazine</mesh_term>
	<criteria>1874 year age Within 50 % ideal body weight great 40 kg Chronic kidney disease ( CKD ) stage 5 receive maintenance hemodialysis least 3 month Native kidney estimate glomerular filtration rate ( GFR ) &lt; 10 mL/min No concurrent illness evidence infection Able give inform consent QTc interval &gt; 470 msec echocardiogram ( ECG ) obtain within last 6 month Concomitant QTprolonging drug , major Pgp inhibitor , CYP3A4 inducer inhibitor include : cyclosporine , rifampin , rifabutin , rifapentine , phenobarbital , phenytoin , carbamazepine , St. John 's Wort , ketoconazole , itraconazole , clarithromycin , nefazodone , nelfinavir , ritonavir , indinavir , saquinavir , quinidine , dofetilide , sotalol , amiodarone , erythromycin , thioridazine , ziprasidone , haloperidol , trimethoprim/sulfamethoxazole , ciprofloxacin , norfloxacin , levofloxacin , moxifloxacin Prestudy hemoglobin &lt; 9.5 g/dL Plasma albumin &lt; 2.5 g/dL Liver disease exclude subject Child Pugh score C higher Positive pregnancy test Breastfeeding Allergy ranolazine Participating another investigational study Hepatitis B infection due dialysis isolation requirement Unstable blood pressure control Need routine large fluid removal dialysis ( &gt; 4L )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>ranolazine</keyword>
	<keyword>end-stage renal disease</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>cardiovascular disease</keyword>
</DOC>